{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:52:13Z","timestamp":1790704333838,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jdcjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jdiacomp.2014.08.007","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:20:52Z","timestamp":1409098852000},"page":"134-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Triple combination of insulin glargine, sitagliptin and metformin in type 2 diabetes: The EASIE post-hoc analysis and extension trial"],"prefix":"10.1016","volume":"29","author":[{"given":"Juliana C.N.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Paule","family":"Dain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Pilorget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Loizeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Echtay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0005","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/S0140-6736(12)60439-5","article-title":"Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): A multicentre, randomised open-label trial","volume":"379","author":"Aschner","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0010","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(13)61500-7","article-title":"Linagliptin for patients aged 70years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: A randomised, double-blind, placebo-controlled trial","volume":"382","author":"Barnett","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1464-5491.2010.02941.x","article-title":"Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: A meta-analysis of randomized clinical trials","volume":"27","author":"DeFronzo","year":"2010","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0020","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00125-009-1352-5","article-title":"Megatrials in type 2 diabetes. From excitement to frustration?","volume":"52","author":"Del Prato","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0025","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/MLR.0b013e3181bd4783","article-title":"Characteristics of insured patients with persistent gaps in diabetes care services: The Translating Research into Action for Diabetes (TRIAD) study","volume":"48","author":"Gregg","year":"2010","journal-title":"Medical Care"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes","volume":"46","author":"Kahn","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0040","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1185\/03007995.2012.703134","article-title":"Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: A pre-specified analysis adjusting for the most recently measured HbA(1c) value","volume":"28","author":"Krobot","year":"2012","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0045","first-page":"e35","article-title":"Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A systematic review and mixed-treatment comparison meta-analysis","volume":"5","author":"McIntosh","year":"2011","journal-title":"Open medicine"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/dmrr.1092","article-title":"The A1C and ABCD of glycaemia management in type 2 diabetes: A physician's personalized approach","volume":"26","author":"Pozzilli","year":"2010","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0055","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/dc13-0512","article-title":"Personalized management of hyperglycemia in type 2 diabetes: Reflections from a Diabetes Care Editors' Expert Forum","volume":"36","author":"Raz","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0060","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","article-title":"Management of type 2 diabetes: New and future developments in treatment","volume":"378","author":"Tahrani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"The ORIGIN Trial investigators","year":"2012","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.diabres.2008.09.006","article-title":"Use of anti-diabetic drugs and glycaemic control in type 2 diabetes. The Hong Kong Diabetes Registry","volume":"82","author":"Tong","year":"2008","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0080","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: A multicentre randomised parallel-group trial","volume":"371","author":"Weng","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0085","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jdiacomp.2014.08.007_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70137-8","article-title":"Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): Cross-sectional study of a prospective cohort","author":"Yeung","year":"2014","journal-title":"Lancet Diabetes & Endocrinology"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872714002530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872714002530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T04:24:20Z","timestamp":1538281460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872714002530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1056872714002530"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2014.08.007","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple combination of insulin glargine, sitagliptin and metformin in type 2 diabetes: The EASIE post-hoc analysis and extension trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2014.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}